OHRP Response to AHRP re: Surrogate Consent to Research Office of the Secretary Department of Health & Human Services Office of Public Health and Science Office for Human Research Protections Rockville, Maryland E-mail: mcarome@osophs.dhhs.gov August 28, 2002 Vera Hassner Sharav President, The Alliance for Human Research Protection John H. Noble,…
Federal Study Finds No Benefit of New Antipsychotic Drugs – WashPost/Wall StreetJ/NY Times Tue, 20 Sep 2005 The findings of a $44 million government sponsored study, CATIE, published in The New England Journal of Medicine, comparing an older generic antipsychotic to four new atypical antipsychotics, undercut the legitimacy of psychiatry’s…
Bush Plans to Screen Whole US Population for Mental Illness – BMJ Thu, 24 Jun 2004 A second article in the British Medical Journal discloses additional evidence uncovered by Allen Jones, the whistle blower from the Pennsylvania Inspector General’s Office. The first BMJ article focused on the Texas Medication Algorithm…
Medicare Rx Drug Bill Shaped by Drug Industry Blocks Elderly Bargaining Power – NYT Fri, 5 Sep 2003 A drug industry lobbyist is quoted in The New York Times stating: “Having both houses of Congress Republican-controlled was great. Like in Monopoly, when you get to add hotels.” The Medicare prescription…
Ethical Violations / Investigations Today Congressional Investigations Office of Human Research Protections (OHRP) Letters of Determination: http://ohrp.osophs.dhhs.gov/detrm_letrs/lindex.htm Office of Protection from Research Risks* (OPRR) List of Compliance Oversight Investigations Resulting in Restrictions or Actions to federally licensed Institutions between 1990 – 2000. *Reorganized in 2000 as OHRP Mar 30: AHRP…
FDA Commissioner Lester Crawford Resigns – AP Fri, 23 Sep 2005 The Associated Press reports that the embattled FDA commissioner, Lester Crawford, a veterenarian, who headed the agency since Marc McLellan moved over to the Center for Medicare & Medicaid Services, has resigned effective immediately. Contact: Vera Hassner Sharav 212-595-8974…
Prescriptions And Profit_CBS News 60 Minutes Tue, 16 Mar 2004 “Americans pay far more for their prescription drugs than citizens of any place on Earth.” That’s because “The United States is the only industrialized country without some form of control on the prices of drugs.” No wonder the U.S. accounts…
MEMORANDUM Date: June 10, 2002 From: THE ALLIANCE FOR HUMAN RESEARCH PROTECTION Re: Opposition to AB 2328 To: Members of the California Health and Human Services Committee and Staff: Senator Deborah Ortiz (Chair), Mr. John Miller Senator Ray Haynes (Vice Chair), Ms. Debbie Rogers Senator Jim Battin, Ms. Katie Tinney…
AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall Wed, 29 Jun 2005 The FDA is finally taking note of the fact that many drugs prescribed for the treatment of psychiatric problems are CAUSING serious psychiatric and cardiovascular problems in children and adolescents !…
How Health Care in America Became Big Business–And Bad Medicine – OpEd NYT Zoloft NYT Ad Fails to Disclose Suicide risk Mon, 25 Oct 2004 An Op-Ed in Sunday’ New York Times by Time magazine editors, Donald Barlett and James Steele, is a MUST READ assessment of what ails America’s…
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
Medicaid Battles: Law firm With Ties to Drug Makers Joins Fight in Tennessee / NYT Blind Spot Mon, 14 Mar 2005 The Tennessean reports: “An international law firm with ties to major drug manufacturers is providing free legal help to the advocacy group seeking to block the state from cutting…
